Dual radiobiological interpretations of retrospective clinical data: The time factor

International Journal of Radiation Biology

Volumn 79, Issue 7, 2003, Pages 503-509

  Thames, H D ^a   D'Souza, W ^b   Kuban, D A ^c  

^a UNIVERSITY OF MARYLAND   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BEAM THERAPY; BRACHYTHERAPY; CANCER RADIOTHERAPY; CELL POPULATION; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; HEAD CANCER; HUMAN; INTERMETHOD COMPARISON; MELANOMA; NECK CANCER; OUTCOMES RESEARCH; PREDICTION; PRIORITY JOURNAL; PROSTATE CARCINOMA; RADIATION DOSE FRACTIONATION; RADIATION RESPONSE; RADIOBIOLOGY; RANDOMIZED CONTROLLED TRIAL; RETROSPECTIVE STUDY; TIME; TONSIL CARCINOMA;

BRACHYTHERAPY; CELL DIVISION; DOSE FRACTIONATION; HUMANS; MALE; MELANOMA; NEOPLASMS; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; TIME FACTORS; TONSILLAR NEOPLASMS;

EID: 0142178058     PISSN: 09553002     EISSN: None     Source Type: Journal    
DOI: 10.1080/0955300031000140766     Document Type: Conference Paper

References (35)

1. AMDUR, R. J., PARSONS, J. T., FITZGERALD, L. T. and MILLION, R. R., 1990, The effect of overall treatment time on local control in patients with adenocarcinoma of the prostate treated with radiation therapy. International Journal of Radiation Oncology, Biology, Physics, 19, 1377-1381.
2. ANSCHER, M. S., MONTANA, G. S., DODGE, R., GAYDICA, E. F., DEWHIRST, M. W. and PROSNITZ, L. R., 1993, The lack of impact of treatment time on the outcome of definitive radiotherapy for carcinoma of the prostate. International Journal of Oncology, 3, 707-711.
3. BENTZEN, S. M., 1993, Time-dose relationships for human tumors: estimation from non-randomized studies. In H.-P. Beck-Bornholdt (ed.), Current Topics in Clinical Radiobiology of Tumours. Medical Radiology (Berlin: Springer), pp. 11-26.
4. BENTZEN, S. M. and THAMES, H. D., 1991, Clinical evidence for tumor clonogen regeneration: interpretations of the data. Radiotherapy and Oncology, 22, 161-166.
5. BENTZEN, S. M., THAMES, H. D., OVERGAARD, M., HANSEN, P. V., VON DER MAASE, H. and MEDER, J., 1989, Clinical radiobiology of malignant melanoma. Radiotherapy and Oncology, 16, 169-182.
6. BEYER, D. C. and BRACHMAN, D. G., 2000, Failure free survival following brachytherapy alone for prostate cancer: comparison with external beam radiotherapy. Radiotherapy and Oncology, 57, 263-267.
7. BRENNER, D. J. and HALL, E. J., 1999, Fractionation and protraction for radiotherapy of prostate carcinoma. International Journal of Radiation Oncology, Biology, Physics, 43, 1095-1101.
8. D'SOUZA, W. D. and THAMES, H. D., 2001, Is the α/β ratio for prostate cancer low? International Journal of Radiation Oncology, Biology, Physics, 51, 1-3.
9. DALE, R. G., 1985, The application of the linear-quadratic dose-effect equation to fractionated and protracted radiotherapy. British Journal of Radiology, 58, 515-528.
10. 50, and dose-time prescription habits in radiotherapy of head and neck tumours. Radiotherapy and Oncology, 32, 197-200.
11. DUCHESNE, G. M. and PETERS, L. J., 1999, What is the α/β ratio for prostate cancer? Rationale for hypofractionated high-dose rate brachytherapy. International Journal of Radiation Oncology, Biology, Physics, 44, 747-748.
12. FOWLER, J. F., CHAPPELL, R. and RITTER, M., 2001, Is α/β for prostate really low? International Journal of Radiation Oncology, Biology, Physics, 50, 1021-1031.
13. FOWLER, J. F. and LINDSTROM, M. J., 1992, Loss of local control with prolongation in radiotherapy. International Journal of Radiation Oncology, Biology, Physics, 23, 457-467.
14. FU, K. K., PAJAK, T. F., TROTTI, A., JONES, C. U., SPENCER, S. A., PHILLIPS, T. L., GARDEN, A. S., RIDGE, J. A., COOPER, J. S. and ANG, K. K., 2000, A radiation therapy oncology group (RTOG) Phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report to RTOG 9003. International Journal of Radiation Oncology, Biology, Physics, 48, 7-16.
15. HAUSTERMANS, K. M., HOFLAND, I., VAN POPPEL, H., OYEN, R., VAN DE VOORDE, W., BEGG, A. C. and FOWLER, J. F., 1997, Cell kinetic measurements in prostate cancer. International Journal of Radiation Oncology, Biology, Physics, 37, 1067-1070.
16. HORWITZ, E. M., VICINI, F. A., ZIAJA, E. L., DMUCHOSWKI, C. F., STROMBERG, J. S., GUSTAFSON, G. S. and MARTINEZ, A. A., 1997, An analysis of clinical and treatment related prognostic factors on outcome using biochemical control as an end-point in patients with prostate cancer treated with external beam irradiation. Radiotherapy and Oncology, 44, 223-228.
17. KAJANTI, M., HOLSTI, L. R., HOLSTI, P. and MOYKKYNEN, K., 1993, Effect of split-course radiotherapy on survival and local-control in advanced localized prostatic-carcinoma. International Journal of Radiation Oncology, Biology, Physics, 26, 211-216.
18. KING, C. and FOWLER, J. F., 2002, Yes, the α/β ratio for prostate cancer is low or 'Methinks the lady doth protest too much ... about a low α/β that is'. International Journal of Radiation Oncology, Biology, Physics, 54, 626-628.
19. KING, C. R. and FOWLER, J. F., 2001, A simple analytic derivation suggests that prostate cancer α/β ratio is low. International Journal of Radiation Oncology, Biology, Physics, 51, 213-214.
20. KUBAN, D. A., 2002, Presentation. ASTRO 2002 Conference, 12-14 November, 2002, Ottawa.
21. LAI, P. P., PEREZ, C. A., SHAPIRO, S. J. and LOCKETT, M. A., 1990, Carcinoma of the prostate stage B and C: lack of influence of duration of radiotherapy on tumor control and treatment supply. International Journal of Radiation Oncology, Biology, Physics, 19, 561-568.
22. LAI, P. P., PILEPICH, M. V., KRALL, J. M., ASBELL, S. O., HANKS, G. E., PEREZ, C. A., RUBIN, P., SAUSE, W. T. and COX, J. D., 1991, The effect of overall treatment time on the outcome of definitive radiotherapy for localized prostate carcinoma: the radiation therapy oncology group 75-06 and 77-06 experience. International Journal of Radiation Oncology, Biology, Physics, 21, 925-933.
23. MACIEJEWSKI, B., WITHERS, H. R., TAYLOR, J. M. G. and HLINIAK, A., 1989, Dose fractionation and regeneration in radiotherapy for cancer of the oral cavity and oropharynx: tumor dose response and repopulation. International Journal of Radiation Oncology, Biology, Physics, 16, 831-843.
24. RAGDE, H., ELGAMAL, A. A., SNOW, P. B., BRANDT, J., BARTOLUCCI, A. A., NADIR, B. S. and KORB, L. J., 1998, Ten-year disease free survival after transperineal sonography-guided iodine-125 brachytherapy with or without 45 Gy external beam irradiation in the treatment of patients with clinically localized low to high Gleason grade prostate carcinoma. Cancer, 83, 989-1001.
25. RAGDE, H., KORB, L. J., ELGAMAL, A. A., GRADO, G. L. and NADIR, B. S., 2000, Modern prostate brachytherapy, prostate specific antigen results in 219 patients with up to 12 years of observed follow-up. Cancer, 89, 135-141.
26. SAUSE, W. T., COOPER, J. S., RUSH, S., AGO, C. T., COSMATOS, D., COUGHLIN, C. T., JAN JAN, N. and LIPSETT, J., 1991, Fraction size in external beam radiation therapy in the treatment of melanoma. International Journal of Radiation Oncology, Biology, Physics, 20, 429-432.
27. THAMES, H. D., 1985, An 'incomplete-repair' model for survival after fractionated and continuous irradiations. International Journal of Radiation Biology, 47, 319-339.
28. THAMES, H. D. and BENTZEN, S. M., 1995, Time factor for tonsillar carcinoma. International Journal of Radiation Oncology, Biology, Physics, 33, 755-758.
29. THAMES, H. D., D'SOUZA, W. and KUBAN, D. A., 2002, In response to Drs. King and Fowler. International Journal of Radiation Oncology, Biology, Physics, 54, 627-628.
30. THAMES, H. D., KUBAN, D. A., LEVY, L. B., HORWITZ, E. M., KUPELIAN, P. A., MARTINEZ, A. A., MICHALSKY, J., PISANSKY, T., SANDLER, H. M., SHIPLEY, W. U., ZELEFSKY, M. J. and ZIETMAN, A. L., in press, A comparison of alternative biochemical failure definitions based on clinical outcome in 4839 prostate cancer patients treated by external beam radiotherapy between 1986 and 1995. International Journal of Radiation Oncology, Biology, Physics.
31. THAMES, H. D., WITHERS, H. R., PETERS, L. J. and FLETCHER, G. H., 1982, Changes in early and late radiation responses with altered dose fractionation: implications for dose-survival relationships. International Journal of Radiation Oncology, Biology, Physics, 8, 219-226.
32. TUCKER, S. L. and THAMES, H. D., 1983, Flexure dose: the low-dose limit of effective fractionation. International Journal of Radiation Oncology, Biology, Physics, 9, 1373-1383.
33. WITHERS, H. R., PETERS, L. J., TAYLOR, J. M. G., OWEN, J. B., MORRISON, W., SCHULTHEISS, T., KEANE, T., O'SULLIVAN, B., VAN DYK, J., GUPTA, N., WANG, C. C., JONES, P., DOPPKE, R., MYINT, S., THOMPSON, M., PARSONS, J., MENDENHALL, W., DISHE, S., AIRD, J., HENK, M., BIDMEAD, M., SVOBODA, V., CHON, Y., HANLON, A., PETERS, T. L. and HANKS, G. E., 1995, Local control of carcinoma of the tonsil by radiation therapy: an analysis of patterns of fractionation in nine institutions. International Journal of Radiation Oncology, Biology, Physics, 33, 549-562.
34. WITHERS, H. R., TAYLOR, J. M. G. and MACIEJEWSKI, B., 1988, The hazard of accelerated tumor clonogen repopulation during radiotherapy. Acta Oncologica, 27, 131-146.
35. ZELEFSKY, M., HOLLISTER, T. and RABEN, A., 2000, Five-year biochemical outcome and toxicity with transperineal CT-planned permanent I-125 prostate implantation for patients with localized prostate cancer. International Journal of Radiation Oncology, Biology, Physics, 47, 1261-1266.